Geoff Mackay, Managing Director
Geoff Mackay is an experienced chief executive officer with proven success in leading innovative businesses. Geoff is currently president and chief executive officer of AVROBIO. Previously, he was chief executive of Organogenesis Inc., and during his tenure the company treated roughly 1 million patients with living cell therapies, received the first Center for Biologics Evaluation and Research allogeneic cell-therapy approval, and achieved a dominant position within regenerative medicine. He spent 11 years at Novartis, where he held senior leadership positions within the Global Transplantation & Immunology franchise. Geoff plays an active role within the life sciences eco-system, serving as chairman of the Board of MassBio, chairman of the Board of the Alliance of Regenerative Medicine, and advisory council to the Health Policy Commission for Massachusetts.